glp-1/gip/glucagon receptor agonist GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes Retatrutide—A Game Changer in Obesity
Description
Therefore, discussing the pros and cons with your healthcare professional is important
Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss
There are also common side effects in all classes of GLP-1s
GLP-1 agonists can also increase satiety, reduce feelings of hunger, delay gastric emptying, decrease food cravings, and result in an improvement in eating control
YJ: Formal Analysis, Funding acquisition, Supervision, Visualization, Writing review and editing
Most required prior authorization
